Fluconazole in the treatment of severe onychomycosis

International Journal of Dermatology

Volumn 35, Issue 8, 1996, Pages 587-588

  Montero Gei, Fernando ^a   Robles Soto, Miguel Eduardo ^a   Schlager, Hugo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; TRICHOPHYTON RUBRUM;

EID: 0029764758     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb03666.x     Document Type: Article

References (8)

1. Scher RK, Daniel CR. Nails: therapy, diagnosis, surgery. Philadelphia: WB Saunders, 1990.
2. Hay RJ. Onychomycosis: agents of choice. Dermatol Clin 1993; 11:161-169.
3. Korting HC, Schafer-Korting M, Zienicke H. Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob Agents Chemother 1993; 37: 2064-2068.
4. Piérard GE, Arrese-Estrada J, Piérard-Franchimont C. Treatment of onychomycosis: traditional approaches. J Am Acad Dermatol 1993; 29:S41-S45.
5. Hay RJ. Risk/benefit of modern antifungal therapy: focus on hepatic reactions. J Am Acad Dermatol 1993; 29:S50-S54.
6. Stengel F, Robles-Soto M, Galimberti R, et al. Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis. Int J Dermatol 1994; 33:726-729.
7. Piepponen T, Blomqvist K, Brandt H, et al. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. J Antimicrob Chemother 1992; 29: 195-205.
8. Faergemann J, Laufen H. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol 1993; 18:102-106.